From: A coarsened multinomial regression model for perinatal mother to child transmission of HIV
Risk factor | In utero | Perinatal | Intrapartum | |||
---|---|---|---|---|---|---|
 | OR | 95% CI | OR | 95% CI | OR | 95% CI |
Infection endpoint (612 treatment, 1084 control) | ||||||
Treatment vs. control | 0.691 | 0.469, 1.017 | 0.987 | 0.736, 1.323 | 1.404 | 0.928, 2.123 |
Maternal viral load (1 log10 unit) | 2.552 | 1.895, 3.437 | 2.820 | 2.221, 3.579 | 2.873 | 2.023, 4.082 |
CD4 count (100 units) | 1.037 | 0.939, 1.145 | 1.099 | 1.015, 1.190 | 1.172 | 1.033, 1.331 |
Female infant | 0.938 | 0.658, 1.339 | 1.011 | 0.764, 1.338 | 1.101 | 0.733, 1.654 |
Mother nevirapine | 0.549 | 0.248, 1.215 | Â | Â | Â | Â |
Mother and infant nevirapine | Â | Â | 0.628 | 0.387, 1.019 | 0.562 | 0.262, 1.206 |
Infection/death endpoint (632 treatment, 1107 control) | ||||||
Treatment vs. control | 0.873 | 0.632, 1.205 | 1.025 | 0.789, 1.332 | 1.245 | 0.850, 1.825 |
Maternal viral load (1 log10 unit) | 2.299 | 1.786, 2.959 | 2.568 | 2.086, 3.161 | 2.597 | 1.895, 3.558 |
CD4 count (100 units) | 1.043 | 0.959, 1.135 | 1.098 | 1.024, 1.178 | 1.175 | 1.048, 1.318 |
Female infant | 0.883 | 0.650, 1.201 | 1.066 | 0.829, 1.370 | 1.336 | 0.916, 1.949 |
Mother nevirapine | 0.221 | 0.128, 0.381 | Â | Â | Â | Â |
Mother and infant nevirapine | Â | Â | 0.452 | 0.302, 0.678 | 0.546 | 0.277, 1.075 |